Sponsored by
This is the results of 2 trials of the drug Onc-201 for DIPG and DMG. Bottom line is this oral drug with minimal side effects doubles survival. This is in a tumor type that really has no effective treatments. This should be made available now on an emergency basis. This is why we need the Promising Pathway Act. If this bill was passed, we would have had approval of Onc-201 years ago. The current system is outdated.